As of Jan 20
| +0.33 / +13.81%|
The 3 analysts offering 12-month price forecasts for Apricus Biosciences Inc have a median target of 2.85, with a high estimate of 7.00 and a low estimate of 2.70. The median estimate represents a +4.78% increase from the last price of 2.72.
The current consensus among 3 polled investment analysts is to Buy stock in Apricus Biosciences Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.